Products for Research Use Only
RegisterLogin

Bendazac

CAT: 0013-GTR19167378-01Size: 200 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19167378-01Size:200 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Bendazac, also known as Bendazolic acid, is a small molecule investigated for its potential anticataract properties. Research suggests its mechanism may involve inhibiting lens protein denaturation, supporting its study in both in vitro protein stability assays and in vivo cataract models.
CAS Number
20187-55-7
Product Name Alternative
Denaturation, choleretic, Bendazolic acid, Bendazac, cataractogenic, AF-983, AF983, AF 983, antilipidaemic, antinecrotic, Inhibitor, inhibit, inflammatory, protein
Field of Research
Pharmacology & Drug Discovery
Purity
97.06% (May vary between batches)
Solubility
DMSO:60 mg/mL (212.55 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (7.08 mM)
Smiles
C (N1C=2C (C (OCC (O) =O) =N1) =CC=CC2) C3=CC=CC=C3
Molecular Formula
C16H14N2O3
Molecular Weight
282.29
Storage Conditions
-20°C
Notes
For research use only.

Chemical Information

Bendazac

Bendazac is a monocarboxylic acid that is glycolic acid in which the hydrogen attached to the 2-hydroxy group is replaced by a 1-benzyl-1H-indazol-3-yl group. Although it has anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties and has been used for the treatment of various inflammatory skin disorders, its principal effect is to inhibit the denaturation of proteins. Its lysine salt is used in the management of cataracts. It has a role as a non-steroidal anti-inflammatory drug and a radical scavenger. It is a monocarboxylic acid and a member of indazoles.

CAS Number20187-55-7
PubChem CID2313
IUPAC Name2-(1-benzylindazol-3-yl)oxyacetic acid
Molecular FormulaC16H14N2O3
Molecular Weight282.29
XLogP3.1
Topological Polar Surface Area64.4
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count5
Heavy Atom Count21
Formal Charge0
Complexity357
SMILES
C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=N2)OCC(=O)O
InChI
InChI=1S/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20)
InChIKey
BYFMCKSPFYVMOU-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Bendazac
CAS: 20187-55-7
CID: 2313
Formula: C16H14N2O3
MW: 282.29
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight282.29
XLogP33.1
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count5
Exact Mass282.10044231
Monoisotopic Mass282.10044231
Topological Polar Surface Area64.4 Ų
Heavy Atom Count21
Formal Charge0
Complexity357
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
GTR19161207-01Bendazol
GTR19175677-01Bendazol

Alternative Products

CatalogName
TRC-B132600-10GBendazac
GWB-2DAB01Bendazac Antibody
AR-B06208-01Bendazac-d7
HY-17480R-01Bendazac (Standard)
A17607-1000Bendazac 1g
A17607-200Bendazac 200mg
FB148803-01Bendazac sodiumsalt
A17607-500Bendazac 500mg
591280Bendazac lysine

Popular Products